StonvexLoading…
StonvexStonvexStonvexCore line items from RHP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.58B | $2.34B | $2.16B | $1.81B |
Operating Income | $487.01M | $490.83M | $453.68M | $327.15M |
Net Income | $243.43M | $271.64M | $311.22M | $134.95M |
EPS (Diluted) | $3.77 | $4.38 | $5.36 | $2.33 |
Total Assets | $6.18B | $5.22B | $5.19B | $4.04B |
Total Liabilities | $4.97B | $4.28B | $4.27B | $3.63B |
Cash & Equivalents | $471.42M | $477.69M | $591.83M | $334.19M |
Free Cash Flow OCF − CapEx | $232.39M | $168.60M | $350.28M | $330.41M |
Shares Outstanding | 63.01M | 59.90M | 59.71M | 55.17M |